Chemours Files 8-K on Financials

Ticker: CC · Form: 8-K · Filed: 2024-03-28T00:00:00.000Z

Sentiment: neutral

Topics: financial-results, 8-k

Related Tickers: CC

TL;DR

Chemours dropped its 8-K on financial results today.

AI Summary

On March 27, 2024, The Chemours Company filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits related to its operations. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing provides investors with crucial updates on Chemours' financial performance and operational status, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing?

The primary purpose of this Form 8-K filing is to report on the Results of Operations and Financial Condition of The Chemours Company, along with Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 27, 2024.

In which state is The Chemours Company incorporated?

The Chemours Company is incorporated in Delaware.

What is the fiscal year end for The Chemours Company?

The fiscal year end for The Chemours Company is December 31.

What is the principal executive office address for The Chemours Company?

The principal executive office address for The Chemours Company is 1007 Market Street, Wilmington, Delaware 19801.

From the Filing

0000950170-24-037412.txt : 20240328 0000950170-24-037412.hdr.sgml : 20240328 20240327180911 ACCESSION NUMBER: 0000950170-24-037412 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240327 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24792453 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20240327.htm 8-K 8-K false 0001627223 Chemours Co 0001627223 2024-03-27 2024-03-27     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   March 27, 2024 Date of Report (Date of Earliest Event Reported)   The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐         Item 2.02 Results of Operations and Financial Condition.   On March 27, 2024, The Chemours Company (the “Company”) issued a press release regarding its fourth quarter and full year 2023 financial results. A copy of the press release is furnished hereto as Exhibit 99.1. The Company will post to its investor relations website, investors.chemours.com, an investor presentation and prepared remarks by 8:00 a.m. Eastern Daylight Time on Thursday, March 28, 2024, for its conference call scheduled for that time.   The information furnished with this report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Ex

View on Read The Filing